注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
United Therapeutics Corp是一家生物技術公司。該公司專注於產品的開發和商業化,以滿足慢性病和危及生命的疾病患者未滿足的醫療需求。該公司在美國營銷和銷售四種治療肺動脈高壓(PAH)的商業療法:Remodulin(曲前列環素)注射液、包括Tyvaso吸入系統的Tyvaso(曲前列環素)吸入溶液、Orenitram(曲前列環素)緩釋片和Adcirca(他達拉非)片劑。該公司還在美國營銷和銷售腫瘤產品Unituxin(dinutuximab)注射液,該注射液被批准用於治療高危神經母細胞瘤,以及Remodulin的Remunity Pump。該公司還從事再生醫學、異種移植、離體肺灌注等多項器官移植相關技術的早期研發。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Martine A. Rothblatt | 68 | 1996 | Founder, Chairman & CEO |
Christopher Causey | 60 | 2003 | Independent Director |
Raymond A. Dwek | 81 | 2002 | Independent Director & Member of the Scientific Advisory Board |
Christopher Patusky | 59 | 2002 | Independent Vice Chairman & Lead Independent Director |
Louis W. Sullivan | 90 | 2002 | Independent Director & Member of the Scientific Advisory Board |
Raymond C. Kurzweil | 75 | 2002 | Independent Director |
Thomas G. Thompson | 81 | 2010 | Independent Director |
Katherine J. Klein | 66 | 2014 | Independent Director |
Mardi Gomberg-Maitland | - | - | Member of the Scientific Advisory Board |
Robert C. Bourge | - | - | Member of the Scientific Advisory Board |
Magdi H. Yacoub | 87 | - | Member of the Scientific Advisory Board |
Linda Maxwell | 48 | 2020 | Independent Director |
Richard Giltner | 59 | 2009 | Independent Director |
Judy D. Olian | 71 | 2015 | Independent Director |
Samuel O. Thier | 85 | - | Member of the Scientific Advisory Board |
Nilda Mesa | 63 | 2018 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核